Research Interests of the School

The major research directions are 1) Chinese Medicine for aging-related diseases/conditions such as cardiovascular and cerebral vascular diseases; 2) Chinese Medicine for cancer or cancer treatment related disorders; 3) Chinese Medicine for mental disorders; 4) Chinese Medicine for pain management; and 5) Quality control for Chinese herbal medicine. The research projects are supported by the People’s Republic of China government, Hong Kong SAR government, various internal grants and donations. Over 600 SCI papers have been published in authoritative international journals in recent years and have obtained different patents in the U.S. and China.

Professor LX Lao, Professor, Vivian Taam Wong Professorship in Integrative Medicine

Verification of the effectiveness and mechanism of acupuncture and Chinese medicine using rigorous scientific design; Conducting translational research that bridges basic science, clinical trials, and “real world” acupuncture and Chinese Medicine clinical practice; and Examining the efficacy of acupuncture and Chinese Medicine for the treatment of pain conditions, e.g. low back pain, post-operative pain, chronic pain, cancer pain, neuropathic pain, neuropathic pain, osteoarthritis, frozen shoulder, etc.

Professor JG SHEN, Professor

Development of molecular targets and drug discovery from Traditional Chinese Medicine, targeting cerebral-ischemia reperfusion injury, post-stroke recovery and neuroinflammations, from clinical study, basic research to translational medicine.

Professor ZJ Zhang, Professor

Seek novel psychotropic agents and developing effective treatment strategies from Traditional Chinese Medicine and acupuncture against major psychiatric disorders; Characterize psychopharmacological and psychotherapeutic properties of novel compounds derived from medicinal plants, Explore neural mechanisms of broad therapeutic effects of acupuncture; Identify epidemiological and pharmacokinetic herb-drug interactions; and Identify the pathogenesis of major neuropsychiatric disorders.

Dr YB Zhang, Principal Lecturer

Methodology study 0 quality analysis on the Chinese medicines (MQCM) by molecular biology and chemistry. The research will focus on scientific methodology explorations including molecular biology and chemistry; and Screening bioactive components of Chinese medicines for Alzheimer's disease (AD) and Parkinson’s disease (PD).

Dr JP Chen, Associate Professor

Identification and characterization of novel biomarkers relating to cancer drug resistance and metastasis; Identification and characterization of molecular targets and mechanisms of natural anti-cancer drugs; Effects and molecular mechanism exploration of TCM formula or compounds for breast cancer prevention; and Relationship between breast cancer and liver in literature lab and clinical research.

Dr Y Feng, Associate Professor

Standardization and quality control of Chinese medicines, Pharmacological screening and safety evaluation of Chinese medicines; and Pharmacological action and its mechanism of Chinese medicines. From the perspectives of Traditional Chinese Medicine and biomedicine as well as science, the research will concentrate on clinical trial and experimental study for hard-to-cure diseases, such as cancer, hepatic diseases, and renal diseases by using recently developed techniques in OMICS, molecular biology and immunology.

Dr L Li, Associate Professor

Cultural studies on Chinese Medicine; Literature studies on Chinese Medicine; Clinical studies on acupuncture and moxibustion, and Study on the effectiveness of acupuncture at different times.

Dr J Rong, Associate Professor

Neuroprotective botanicals for enhancing neuronal survival and neurogenesis in ageing, major depression, Parkinson’s disease and Alzheimer’s disease; and Cardioprotective botanicals for regulating infiltration of macrophages / neutrophils and promoting cardiac regeneration in acute myocardial infarction; Long-term objective is to develop novel chemically-defined and mechanism-specific medicines for the treatment of neurodegenerative and cardiovascular diseases; The on-going research focuses on dissecting the interactions between the active compounds from complex herbal medicines and protein targets, especially those with high relevance to the resolution of inflammation and tissue repair.

Dr HY Chen, Research Assistant Professor

Evidenced Based Chinese Medicine (systematic review, meta-analysis and RCTs); Molecular mechanism of inflammatory and fibrotic diseases (e.g. diabetic nephropathy); and Mechanism of Chinese Medicine and acupuncture for inflammatory diseases and pain.

Dr N Wang, Assistant Professor

Quality control and standardisation of Chinese herbal Medicine; Molecular pharmacology of Chinese herbal Medicine in treating metabolic disorders (obesity, hepatic diseases and diabetes mellitus, etc.) and cancers; Chemical profile-biological response relationship of Chinese Medicine formulas; Pharmacokinetics and herbal-drug interaction of Chinese herbal Medicine; Translational study and drug discovery in natural products and Chinese Medicine formula